Viewing nowCombinationAmloTel 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.

MFDS item code 201702240 · Approved 2017.04.28 · Insurance code 662503640
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with amlodipine or telmisartan alone. It effectively lowers blood pressure, helping to control hypertension and reduce the burden on the heart and blood vessels to maintain health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine); however, switching directly to this medicine may be considered when blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams and 80/10 milligrams). ○ Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this medicine’). In elderly patients 75 years of age and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Pediatric patients aged 18 years or younger: The safety and efficacy have not been established; therefore, administration of this drug is not recommended.
This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, and should not be used by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as liver impairment, severe hypotension, heart disease, nursing mothers, and those with hypersensitivity to specific medications. Patients with primary aldosteronism or aortic stenosis, hypertrophic obstructive cardiomyopathy, etc., require special caution when using this medication. Dose adjustment is necessary for patients with impaired liver function, and patients with gastrointestinal diseases should also use this medication cautiously. Care should be taken when administering this medication to patients with poor kidney function, those on dialysis, and elderly patients. This medication can cause various side effects, such as dizziness, peripheral edema, and hypotension, so if abnormal symptoms occur, consult a doctor immediately. Should hypotension symptoms appear due to excessively low blood pressure, the patient should be laid down and intravenous fluids may be necessary. As this medication can interact with other drugs, patients should inform their doctor or pharmacist if they are taking other medications. Nursing mothers should avoid taking this medication, and it should also be avoided in case of pregnancy plans or if pregnant. Administration in pediatric patients is not recommended, as safety and efficacy have not been sufficiently established. In case of overdose, symptoms such as hypotension, dizziness, heart problems may occur, and immediate medical attention should be sought. This medication should be kept out of the reach of children, and it is advisable not to transfer it to another container. It is crucial to take the medication directly from its packaging to maintain drug quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects from light, at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's efficacy for an extended period.
White or off-white rectangular tablets
30 tablets/box [(10 tablets/Alu-Alu x 3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.